COMPANY PROFILE

Soley Therapeutics

Explore full profile

Drug discovery and development company using cellular responses and AI to identify novel therapies for complex diseases

Brentwood, United StatesFounded 2020Biotech & Life Sciences

Valuation $500M–1B Last recorded · 2026

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Soley Therapeutics

Soley Therapeutics operates in the life sciences sector, focusing on the discovery and development of new drugs. The company utilizes a groundbreaking high throughput platform technology that uses cells as natural sensors to interpret nuanced cellular responses. This technology, combined with the power of artificial intelligence (AI) and machine learning (ML), allows Soley Therapeutics to efficiently and effectively identify potential drug candidates. The company serves pharmaceutical and biotechnology firms, aiming to meet the unmet needs of patients by revolutionizing drug discovery and development. Soley Therapeutics generates revenue through partnerships, licensing agreements, and the sale of developed drugs. The company is committed to scientific rigor, continuous innovation, and creating benefits for patients in need. It also prioritizes an attractive work environment that stimulates and rewards collegiality, creativity, and disciplined productivity. Soley Therapeutics is based in San Francisco and is actively expanding its team of scientists, high throughput screening automation experts, security and IT specialists, and AI/ML engineers.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2020
Headquarters: Brentwood, United States
Employees: 37
Open positions: 2
Dealroom signal: 81.2/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Oncology, Drug Development, Medical & Healthcare, Spinout, Tech for Biotech and Pharma
Technology: Artificial Intelligence, Computer Vision
Business model: Manufacturing, SaaS
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Jan 2026	$200M	$800M	Breyer Capital · HRTG Partners · RWN Management · GordonMD Global Investment	↗
SERIES BOther financing	Jan 2022	$70M	$280M	Undisclosed	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Soley Therapeutics website traffic

Latest recorded traffic for Soley Therapeutics is 2.5K monthly website visits, down 16.7% over the last three months. Soley Therapeutics's team grew 2.8% over the past year.

Latest monthly visits2.5K 3-month web change-16.7% 1-year team growth+2.8%

Monthly website visitsAug 2024–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Data Operations/Inventory CoordinatorSouth San Francisco, CA · Data Science & Engineering · Jul 25, 2026

1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ELEpigene LabsHelping cancer researchers develop new treatments and drugs by providing them with data-driven insights	Paris, France	Operational	15	$1.5M	$6.2M
OTOdyssey TherapeuticsBuilding a machine learning-based platform to develop novel therapeutics focusing on cancer and autoimmune diseases	Boston, United States	Operational
OWOwkinCollaborative research platform and unique AI drug development solutions that make precision medicine a reality	Paris, France	Operational
MTMnemo TherapeuticsDeveloping powerful cell therapies that create accessible cures for solid tumors and blood cancers. EnfiniT platform, a groundbreaking drug discovery engine	Paris, France	Low Activity
RBRidge BiotechnologiesAI-enabled platform for precision enzyme and drug design	Palo Alto, United States	Operational
PEPepticomAn Artificial Intelligence (AI) company for the discovery of novel molecules in the Pharmaceutical and Agricultural markets	Jerusalem, Israel	Operational
OKOkomeraOkomera is pioneering automation and miniaturization of personalized tumor biopsy studies	Paris, France	Operational
GBGenerare BioscienceBioactive molecule discovery platform from microbial DNA	Paris, France	Operational